-
Commercial Genome Service Launches Based on Open Data
A start-up software company is offering genetic analysis services for research and precision medicine that comply with open standards and access Google’s genomic data sets.
-
Trial Testing Retina Cell Implants for Glaucoma
A new clinical trial is testing implants to treat glaucoma made of genetically engineered retina cells that release hormones promoting optic nerve growth.
-
Sweat Sensor Devised for Blood Glucose Measurement
A bioengineering lab at University of Texas in Dallas developed a miniature biosensor device that measures blood glucose levels from a person’s perspiration.
-
Therapeutic Food-Triggered Gut Microbes in Development
A biologist at Rice University in Houston is developing synthetic intestinal microbe circuits that respond to food to release therapeutic proteins.
-
Yom Kippur 5777
We’ll be observing Yom Kippur today, the day of atonement and holiest day in the Jewish calendar. Regular posting will resume tomorrow.
-
Worms-On-A-Chip Drug Screening System Designed
A system using live roundworms on a microfluidics chip and high-speed image analysis can quickly and simultaneously screen nearly 100 drug compounds.
-
Trial Shows Ovarian Cancer Drug Safety, Therapy Potential
A clinical trial shows an experimental therapy addressing a common cancer-causing mutation is safe, with early indications of its efficacy against ovarian cancer.
-
Breast Cancer Drug Costs Vary Among Insured Patients
Women receiving chemotherapy for breast cancer can face widely different costs for their treatments, regardless of effectiveness, even if they have health insurance.
-
Funds Provided for Developing RNA-Based Zika Vaccine
Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus.
-
Grant Funding Study of Gut Microbe Protection Drug
A biotechnology company developing drugs that protect the natural microbial balance in the gastrointestinal tract is receiving funds to learn how its drugs affect antibiotic resistance.